MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)

Summary

A study to assess the safety and efficacy of MK0974 for preventing migraines in patients with episodic migraine.

Timeline

Start

2008-11-12

Primary completion

2009-05-20

Completion

2009-05-20

Publications

• Results Ho TW, Connor KM, Zhang Y, Pearlman E, Koppenhaver J, Fan X, Lines C, Edvinsson L, Goadsby PJ, Michelson D. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention. Neurology. 2014 Sep 9;83(11):958-66. doi: 10.1212/WNL.0000000000000771. Epub 2014 Aug 8.

Drugs

Indications